Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
about
Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practiceFerroptosis: Death by Lipid Peroxidation.The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.Differences in gene expression profiles and signaling pathways in rhabdomyolysis-induced acute kidney injuryElevated serum creatine phosphokinase is associated with mortality and inotropic requirement in critically injured adultsPeroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.Hemojuvelin modulates iron stress during acute kidney injury: improved by furin inhibitor.A review on the role of quinones in renal disorders.Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.Protective Role for Antioxidants in Acute Kidney DiseaseDynamic changes in Bach1 expression in the kidney of rhabdomyolysis-associated acute kidney injury.Rhabdomyolysis. The role of diagnostic and prognostic factors.Selenium inhibits renal oxidation and inflammation but not acute kidney injury in an animal model of rhabdomyolysis.[Rhabdomyolysis and creatine kinase elevation].Assessment of acute kidney injury in rhabdomyolytic mice by transcutaneous measurement of sinistrin excretion.Evaluations of lipid peroxidation and inflammation in short-term glycerol-induced acute kidney injury in rats.The Preventive Role of Pioglitazone in Glycerol-Induced Acute Kidney Injury in Rats during Two Different Treatment Periods.
P2860
Q26746093-3A03345C-069C-4F87-AA4C-24C51CC707BAQ34045575-4130E17F-DBAB-4A07-83BE-5B62B394C413Q34347558-3268D0B5-E4C3-4B5E-B068-6D220336FA19Q36464344-1981DC41-7AF3-4F00-B2F6-C021C0E82EB4Q36927226-BCEF4F52-039B-4266-AA55-AD2AA68030D8Q37213764-6C15CB92-FA24-4838-B956-884EE7511337Q37297179-2673E28B-73C9-4C9D-AC7A-F990B0F7AB53Q37602863-1BD5DBFA-9412-473E-A63C-8DD7820ACECEQ38098184-2358E4E4-CFEF-4908-9EF3-0EF2EEEF727CQ39040278-34494255-5E07-47D5-A805-6A5CAEBEDE06Q39420751-4A63B8CE-7D2C-45F6-8A5A-E4770DE89509Q41007378-DCD48898-3A29-413C-88D1-64CE8E38158AQ41845560-2E3316EF-3434-40F5-80C6-5EDE8086018CQ42977559-000483AA-4451-48B3-8E84-7F126B39BF9AQ44914071-D83DD046-2127-4DFB-9A06-E409BD10A9A1Q50775801-D0D73DE7-1751-4945-A544-825BD0BE91B7Q51568839-A101D083-3438-4A9D-810F-28A3FA123621Q54985660-846FD038-238C-43A9-AA98-D771847AECAB
P2860
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
@en
type
label
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
@en
prefLabel
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
@en
P2860
P1476
Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure
@en
P2093
L Jackson Roberts
Olivier Boutaud
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.10.704
P577
2010-10-27T00:00:00Z